Tag: medicine

Summit, Colorado Center for Personalized Medicine to Develop Saliva Tests for COVID, Head & Neck Cancer

October 14, 2020
 |  No Comments
 |  medicine

AURORA, Colo., Oct. 14, 2020 /PRNewswire/ — Summit Biolabs, Inc., an early-stage molecular diagnostics company specializing in saliva-based testing for COVID-19 and head & neck cancer, and the Colorado Center for Personalized Medicine (CCPM) at the University of Colorado Anschutz Medical Campus announced today a broad strategic collaboration involving research, development and commercialization of saliva liquid-biopsy tests for early cancer detection and diagnosis of COVID-19 and other viral contagions.

The CCPM holds one of the largest research biobanks in the United States with clinical data from more than 8.7 million de-identified patient records and plans to integrate the data with personalized genomic information.

“This partnership brings two innovative programs together to optimize COVID testing at a time when it’s desperately needed,” says Kathleen Barnes, Ph.D., Professor and Director of CCPM at the University of Colorado Anschutz Medical Campus. “Collaborations like this are crucial in moving research forward and advancing and expanding clinical testing to as many members of our community as possible. Working with Summit Biolabs, and leveraging technology developed by our colleagues here at the Anschutz Medical Campus, will help us achieve these goals and establish a non-invasive testing process that will benefit patients in Colorado and beyond.”

Summit Biolabs is developing breakthrough tests to improve the detection of COVID-19 and to advance the early detection of human cancers, including head & neck cancer, using simple, non-invasive saliva liquid-biopsy technology developed by Dr. Shi-Long Lu and colleagues at the University of Colorado Anschutz Medical Campus. Head & neck cancer has been scientifically overlooked, yet is medically important. Summit Biolabs’ research foundation and competency in head & neck cancer diagnosis enabled the company’s pivot to saliva-based testing for coronavirus, COVID-19.

“We are excited to collaborate with CCPM to develop and commercialize Summit Biolabs’ portfolio of developmental saliva or non-blood liquid-biopsy tests.” said Bob Blomquist, Chief Executive Officer at Summit Biolabs. “This collaboration broadens and strengthens Summit Biolabs’ ability to bring to market life-changing saliva liquid-biopsy tests that ultimately enable better treatment and improved outcomes for patients.”

About Summit Biolabs

Summit Biolabs is harnessing the power of saliva-based diagnostics to address critical challenges in COVID-19 and head & neck cancer testing. Founded on the discoveries of Dr. Shi-Long Lu, Associate Professor of Otolaryngology, Summit Biolabs is being spun out from the University of Colorado Anschutz Medical Campus.

Summit Biolabs is pioneering early detection of head & neck cancer recurrence using a first of its kind saliva liquid-biopsy test, HNKlear. HNKlear is a proprietary, non-invasive saliva test that provides more effective, more accurate, and earlier detection of head and neck cancer recurrence than traditional diagnostic methods. Summit Biolabs is leveraging its core competencies in saliva-based molecular diagnostics and viral nucleic acid testing (i.e., oral oncogenic human papillomavirus detection) to diagnose COVID-19. Along with our clinical and laboratory partners, Summit Biolabs is developing the first comprehensive panel of highly-accurate saliva-based tests for COVID-19 infection, quantitation, and immune response. Summit Biolabs is headquartered in Aurora, Colorado.

About

… Read More →

Summa Equity Acquires Sengenics to Advance Precision Medicine Through Proteomics

 |  No Comments
 |  medicine

Summa Equity, the purpose-driven private equity firm that invests to solve global challenges, has acquired a majority stake in Sengenics, a functional proteomics company with a proprietary technology called KREX that enables researchers to vastly improve the understanding of the human proteome and immune system. Proteomics, i.e. the large-scale study of proteins, is one of the most important areas for gaining insights into human biology and disease, as protein expressions, structures and functions are critical in reflecting states of health.

Sengenics was first founded in 2008 and went on to commercialise the KREX technology that was originally developed from a joint collaboration between the University of Cambridge and the University of Oxford. The company’s patented KREX technology enables researchers to address both the function and folding structure of proteins using one technology that allows for large numbers of proteins to be studied simultaneously, with high sensitivity and specificity. The combination of these capabilities makes KREX unique. The technology is relevant for a broad range of applications in research and throughout the value chain for drugs, vaccines and diagnostics. Sengenics is currently mainly focused on autoantibody detection for applications in autoimmune diseases, oncology and infectious diseases, including COVID-19. The company recently launched a unique high-throughput, multi-antigen, multi-domain and fully quantitative COVID-19 test, leveraging the KREX technology.

Sengenics has grown rapidly in recent years and established customer relationships with top global pharmaceutical companies, and leading research and academic institutions around the world. The company currently has commercial partnerships with 9 out of the top 10 pharmaceutical companies to co-develop complementary and companion diagnostic tests for autoimmune and cancer immunotherapy drugs. Sengenics is based in Europe and South-East Asia.

“Sengenics’ proprietary technology unlocks tremendous potential for researchers around the world to further their understanding of biology and disease,” says Tommi Unkuri, Partner at Summa Equity. “We are proud to partner with the company and support its journey, as it looks to expand its position in the market and grow its business. We look forward to supporting the Sengenics team in our shared ambition to invest to drive product development, global expansion and accelerated adoption.”

Summa Equity invests in companies that address global challenges, while managing environmental, social, and governance (ESG) factors, with the aim of increasing returns and reducing risk. It was the first company to align its investments with the UN Sustainable Development Goals. The investment in Sengenics is aligned with the firm’s Changing Demographics theme and supports the SDG Target #3: “Ensure healthy lives and promote well-being for all at all ages”, by enabling improved diagnosis, treatment and patient outcomes across a number of disease areas.

“We are excited to welcome Summa Equity as a major strategic investor and shareholder in Sengenics. Their extensive capabilities and alignment with our vision of changing the future of medicine through immune-proteomics is a very strong strategic fit. Summa also has a great deal of relevant knowledge and experience to be a value-added owner for us given its ownership of Olink Proteomics. This

… Read More →

Launch a Global Medical Career with Manipal’s American University of Antigua, College of Medicine

 |  No Comments
 |  medicine

Medical students can be an efficient contingency workforce, provided their lack of training is suitably addressed. Being capable and ready to respond to COVID-19 like pandemic situation needs crucial emphasis on disaster management and emergency medicine. The world is faced with the reality of the shortage of physicians and healthcare providers due to the challenges posed by the current epidemiological peak. From the larger perspective, it is about how the shortage of physicians worldwide is going to impact the global health scenario. A lack of training renders medical students non-essential to patient care; on the other hand, clinical training is essential to generate future responders against COVID-19. What should be the focus of medical institutions and aspiring medical students?

Manipal’s American University of Antigua College of Medicine (AUA) is one such renowned institute in the Caribbean that helps students from different corners of the world to fulfill their dreams of becoming doctors. For nearly two decades, the university is training future physicians and offering a Doctor of Medicine (MD) degree. Gaining Experience in global healthcare is the way forward. AUA provides knowledge on global healthcare through its Global Health Track, which is conducted in collaboration with Florida International University (FIU). The purpose of the Global Health Track is to support and guide students in developing expertise in global health issues with the goal of subsequent career involvement involving patient care, service, policy making, research and education at a global level. 

Not all international medical universities and schools provide the opportunity to practice medicine in the US, Canada, the UK as well as in India. AUA’s curriculum is evaluated regularly to ensure that it is as per the standards of its USA and Canadian counterparts. AUA has collaborations/affiliations with many foreign universities like Florida International University (in the US), The University of Warwick (in the UK), and many others. Surrounded by beautiful nature with warm hospitality received from the people of the Caribbean region, AUA surely stands out to be a place to build a career in medicine and more than 3,000 students of AUA have graduated and are practicing in the US, Canada and the UK.

Manipal’s AUA emphasizes the need for well-rounded doctors. Hence, equal importance is given to the academic performance as well as emotional intelligence. The admission process is holistic that considers more than just the test scores. 

Alumnus Dr. Nandita Mahajan shares, “If anyone is planning to go for higher education in medicine, they should choose to go to AUA.”

The alumni of Manipal’s AUA stand testimonial to the difference being made by this institution in India as well as India’s contribution to global healthcare. The choice is usually driven by: greener pastures, studying abroad, acquiring a mere medical degree or contributing towards the larger purpose of improving the global healthcare scenario. 

Another alumnus Dr. Nandini Chattopadhyay reminisces, “The teaching that one receives in pre-clinical sciences in AUA, lay the foundation for clinical sciences. Everybody in AUA is always eager to help in

… Read More →

Advanced ICU Care and UAB Medicine Enter Strategic Telemedicine Partnership

 |  No Comments
 |  medicine

ST. LOUIS, Mo., Oct. 13, 2020 /PRNewswire/ — Advanced ICU Care, the nation’s leading provider of high-acuity telemedicine services, announced a large strategic telemedicine partnership with UAB Medicine, a nationally recognized leader in patient care, research and training. The technology, operations, and care partnership encompasses the entire UAB Health System including University of Alabama at Birmingham Hospital, the third largest public hospital facility in the U.S. The relationship initiates with the development of a new tele-ICU operations center in Birmingham and envisions serving up to 750 ICU beds in Alabama and surrounding states.

The new partnership brings together leading healthcare innovators to advance the practice and operational models of tele-ICU care. UAB Medicine’s desire to provide state-of-the-art tele-ICU services for its ICU units led to extensive evaluation of tele-ICU options. Advanced ICU Care has developed unique assets and experience in its fifteen years of offering telemedicine care.

In particular, Advanced ICU Care’s proprietary HUB workflow management software platform uniquely addresses the challenges associated with the customized delivery of acute patient care at high volumes across multiple care venues. In addition, the company’s technical, operational, and clinical expertise draw upon its care of over a half million tele-ICU patients and care partnerships with more than 100 hospitals nationwide. UAB Medicine brings to the relationship additional clinical expertise as a national leader in pulmonary and critical care medicine.

 “Advanced ICU Care’s clinical and operational expertise and proprietary HUB workflow management software are assets that are well aligned with UAB’s vision for our tele-ICU programs,” said Reid Jones, CEO of UAB Medicine. “Telehealth and tele-ICU have become increasingly important vehicles for healthcare delivery, and we look forward to leveraging Advanced ICU Care’s assets to deliver high-acuity telemedicine to patients across Alabama and beyond.”

“The size and scope of this unique tele-ICU services partnership is indicative of the forward looking, innovation-oriented cultures of both organizations,” said Lou Silverman, CEO of Advanced ICU Care. “As a technology-enabled healthcare services organization, we have successfully implemented and managed more tele-ICU programs than any other provider in the nation. We see this partnership as an endorsement of the successes we have achieved to date and as a validation of our vision for the future of telemedicine. We look forward to collaborating closely with the UAB Medicine team in this inspired project.”

About UAB Medicine

UAB Medicine comprises the School of Medicine and the $4.3 billion UAB Health System that includes all of the University of Alabama at Birmingham‘s patient-care activities and 2,300 licensed beds in six hospitals, one of which is UAB Hospital — the third-largest public hospital in the United States, winner of the Women’s Choice award, and one of U.S. News & World Report’s Best Hospitals. UAB, a part of the University of Alabama System, is the state of Alabama’s largest single employer and an internationally renowned research university and academic health center; its professional schools and specialty patient-care programs are consistently ranked among the nation’s top 50. UAB is the

… Read More →

Executive Medicine of Texas puts the Spotlight on Alzheimer’s Disease

 |  No Comments
 |  medicine

Deaths from Alzheimer’s disease are increasing exponentially, but gaining little attention from the general public due to the Covid19 pandemic and other issues. Executive Medicine of Texas is working diligently to change the narrative and place focus on education and prevention of this terrible disease. Their first move, is hosting the first Alzheimer’s and the Arts Event, which will showcase the film “Have You Heard about Greg?”

DALLAS (PRWEB) October 13, 2020

According to the Alzheimer’s Association, since the year 2000, deaths from Alzheimer’s have increased by 146%. This is while deaths from heart disease have decreased by 7.8%. Alzheimer’s Disease is the sixth leading cause of death in the US, claiming more lives than breast cancer and prostate cancer combined.

“Our patients are concerned about their brain health and so are we,” says Mark Anderson, MD and one of the founders of Executive Medicine of Texas. “Years ago we made cognitive testing part of our routine executive exams. Shockingly, we’ve seen a significant number of patients, younger than ever, who are complaining of some sort of cognitive disruption. As a physician, it’s alarming.”

The Alzheimer’s and the Arts Event is the first of many efforts that Executive Medicine of Texas will be pushing to raise awareness for the disease. “This is a special event,” states Judy Gaman, their CEO, “because we’re focusing on education while raising money for the Alzheimer’s Association and the Guzman 23 Foundation.” Gaman, who knows from family experience just how devastating this disease can be, is championing the effort. “Having people like Steve Ecclesine, Greg O’Brian, and Warren Honeycutt involved so heavily in the Alzheimer’s and the Arts event brings it to a whole new level.

Steve Ecclesine, a Hollywood producer with over 700 films and TV shows to his credit is the producer of the film Have You Heard about Greg? He will be at the event for a Q&A session directly following the premier event. The film, showcasing the life of Greg O’Brian as he battles Alzheimer’s, has not yet been released. “I’m very interested to receive feedback from the audience and share the story of how this documentary came to be. Out of all the films I’ve worked on, this one is near and dear to my heart.” Those attendees who wish too will receive a chance to give on-screen testimonials about the films impact that will become part of the films marketing efforts.

Greg O’Brian’s highly acclaimed internationally award-winning book On Pluto: Inside the Mind of Alzheimer’s, is the first book written by an investigative reporter who’s actually inside the mind of Alzheimer’s. Much like the book, the film, Have You Heard about Greg? shows what Greg and others have learned about the disease and uses science, faith, hope, and humor to broach a topic that needs much more attention.

Warren Honeycutt, six-time Mr. America Fitness finalist, media fitness expert and author of the book How the Health Are You? has also worked tirelessly on this project and will be at

… Read More →

Disc Medicine Expands Scientific Advisory Board with Leading Experts in Hepcidin Biology

 |  No Comments
 |  medicine

CAMBRIDGE, Mass., Oct. 13, 2020 /PRNewswire/ — Disc Medicine, a company dedicated to the discovery and development of novel therapeutic candidates for serious and debilitating hematologic diseases, today announced the appointment of Tomas Ganz, MD, PhD and Elizabeta Nemeth, PhD to its scientific advisory board, adding valuable expertise in hepcidin biology.

“We are thrilled to welcome  Dr. Ganz and Dr. Nemeth to our Scientific Advisory Board, particularly at such an exciting time in a field that they helped pioneer,” said John Quisel, JD, PhD, Chief Executive Officer at Disc Medicine. “Together they were instrumental in characterizing the fundamental role of hepcidin in iron homeostasis, and I’m delighted to be working with them as we advance our hepcidin-targeted programs into the clinic.”

Dr. Ganz is a Distinguished Professor of Medicine and Pathology at the David Geffen School of Medicine at UCLA, where he studies the role of small peptide regulators in human physiology and disease and is credited for the discovery of the iron-regulatory hormone hepcidin. Dr. Ganz received his PhD in Applied Physics from Caltech and his MD from UCLA, joining UCLA as a faculty member in 1983 after having completed training in Internal Medicine and Pulmonary Medicine. In 2005 he received the Marcel Simon Prize of the International Bioiron Society for the discovery of hepcidin and in 2014 was honored by the E. Donnall Thomas Award from the American Society of Hematology for his research in iron homeostasis, including the discovery of the iron-regulatory hormone hepcidin and investigation of its roles in iron metabolism.

“It has been immensely gratifying to see the hepcidin story unfold as our understanding of hepcidin’s role across different diseases has grown,” said Tomas Ganz, MD PhD. “Disc has taken a compelling approach to targeting hepcidin with two programs guided by human genetic findings. I’m delighted to be a part of this vision, particularly as they look to enter the clinic with their first program next year.”

Dr. Nemeth is a Professor of Medicine at the David Geffen School of Medicine at UCLA, and Director of the UCLA Center for Iron Disorders. Dr. Nemeth received her PhD in Cell, Molecular and Neurosciences at the University of Hawaii and completed a postdoctoral fellowship studying the pathobiology of hepcidin at UCLA. During her tenure she has made major contributions to the understanding of iron homeostasis and its dysregulation in disease, such as characterizing the regulation of hepcidin production by inflammation and iron and elucidating the mechanism of action of hepcidin in regulating dietary iron absorption and release from stores. Dr. Nemeth also described the role of hepcidin in various iron disorders including hereditary hemochromatosis, iron-loading anemias and iron-restricted anemias. Dr. Nemeth was a standing member of the Molecular and Cellular Hematology Study Section of the National Institutes of Health, is President-Elect of the International BioIron Society, and an associate editor of the American Journal of Hematology. Dr. Ganz and Nemeth co-founded three biotechnology companies focused on hepcidin-targeted diagnostics

… Read More →

3D metal printer at College of Dental Medicine expands possibilities for innovation

 |  No Comments
 |  medicine

IMAGE

IMAGE: The component that Renne was able to print for the ZIAN team.
view more 

Credit: MUSC

When the Zucker Institute for Applied Neurosciences at the Medical University of South Carolina needed to bring to life a neurosurgeon’s idea for better instrumentation for sacroiliac surgery, there was one obvious partner to turn to: the MUSC College of Dental Medicine.

The college is the only dental program in the nation to have the Sisma Mysint100 3D selective laser fusion printer that creates 3D prints from metal rather than plastic, and Walter Renne, D.M.D., a professor in the Department of Oral Rehabilitation and assistant dean of innovation and digital dentistry, is eager to see what it can do.

“3D printing is how we get stuff from our imagination into reality. One of the issues in the past was most of what we could print was plastic, and plastic degrades. You need something to actually function,” he said. “Now, instead of imagining something and developing a plastic prototype that I can look at, I can imagine something and develop a real, usable final product that can be put into a drill or placed in a patient’s mouth. It’s really exciting to have that at the university.”

The manufacturer, Sisma, donated the printer about six months ago. Renne said Sisma wanted its latest device to find a home in a college that would think up creative and innovative uses for it. Those uses aren’t limited to dentistry, however.

The college and ZIAN have collaborated in the past, so it was natural for ZIAN to turn to Renne and colleagues for help with this project, which started with an idea from Stephen Kalhorn, M.D., a professor in the Department of Neurosurgery.

Kalhorn has worked several times before with ZIAN, a technology accelerator that exists to help MUSC’s medical providers to develop their ideas for new devices or device improvements.

“I run things by them because then I can spend the majority of my time in the operating room actively helping patients,” he said. “I can literally drop off a napkin sketch at a ZIAN engineer’s desk or even less than that. There’s even been times that I’ve just drawn on the dry-erase board in the OR and taken a picture and sent it to them, and they’re off to the races.”

This time, Kalhorn had an idea to improve sacroiliac joint fusion surgery. The sacroiliac joint is where the pelvis and spine meet; it is also a source of lower back pain. Fusion surgery encourages the two bones to grow together into one so there is no wiggle room between the two.

Bony fusion requires three elements, Kalhorn explained: stabilization, such as when a cast is placed on a broken limb; decortication, which is the removal of the top layer of tissue to ensure there’s no cartilage or fibrous material blocking the bone cells from building a bridge between the two bones; and compression, whereby the pressure encourages more bone growth. But nothing on the

… Read More →

Living Health Integrative Medicine Celebrates its 19th Anniversary

 |  No Comments
 |  medicine

Living Health Integrative Medicine, Which Was Founded by Dr. Thomas Chaney and Dr. Stephanie Chaney, Provides a Natural and Effective Integrative Approach to Health

ANNAPOLIS, MD / ACCESSWIRE / October 13, 2020 / Dr. Thomas Chaney and Dr. Stephanie Chaney are pleased to announce that Living Health Integrative Medicine, which they co-founded, is celebrating 19 years in business.

To contact Living Health Integrative Medicine and/or to sign up for their newsletter, please visit https://www.mylivinghealth.com/contact-us/.

As Dr. Thomas Chaney noted, he and Dr. Stephanie Chaney are proud of the way their devotion to integrative medicine has helped Living Health Integrative Medicine to become the leader in holistic wellness throughout Maryland, Washington DC and Northern Virginia.

They also take pride in the fact that they are leaders in functional medicine and physical medicine. They use the most current research and science to help guide the treatments they suggest for their valued patients.

Dr. Thomas Chaney, Dr. Stephanie Chaney and their team of practitioners truly live up to their practice’s name, working as an integrated team to provide everyone with the best possible care and results.

“Our model of integrative medicine incorporates natural therapies and treatments to address the whole body versus simply treating a symptom temporarily,” Dr. Thomas Chaney said.

“Our goal is to help you achieve your health goals and for you to reach your maximum health potential.”

From people who are dealing with the pain associated with neuropathy, to those who are looking for effective physical therapy, require regenerative medicine treatments and/or wish to lose weight or have been diagnosed with diabetes, Dr. Stephanie Chaney said they focus on practicing integrative medicine, which focuses on identifying the root cause of health issues.

“We combine multiple treatment options, such as chiropractic, physical therapy, functional medicine, nutrition, regenerative medicine, diagnostic testing, dietary supplement therapy, detoxification and custom nutrition plans,” she said.

About Dr. Thomas Chaney, Dr. Stephanie Chaney and Living Health Integrative Medicine:

Dr. Thomas Chaney is a Maryland native and the founder and co-owner of Living Health Integrative Medicine, which takes a holistic approach to healthcare. He is the co-author of the best-selling books “Lose the Gluten, Lose your Gut. Ditch the Grain, Save your Brain” and “Defeat Diabetes.” Dr. Chaney is a respected member of the profession with a national reputation for dedication to helping the public improve their health naturally.

Dr. Stephanie Chaney grew up in Ottawa Canada and is the co-owner of Living Health Integrative Medicine. She is a leader in the integrative health field, sharing her knowledge with practitioners and the public. Dr. Chaney is a renowned speaker on holistic health and regular guest on the morning show, Great Day Washington. She has also been featured as a guest natural health expert on FOX, ABC and NBC. She is the co-author of the best-selling books “Lose the Gluten, Lose your Gut. Ditch the Grain, Save your Brain” and “Defeat Diabetes.”

For more information, please visit https://www.mylivinghealth.com/.

Living Health Integrative Medicine
1833 Forest Drive, Suite A
Annapolis, MD

… Read More →

UNE to move its College of Osteopathic Medicine to Portland

 |  No Comments
 |  medicine

BIDDEFORD, Maine (AP) — Funding from the Harold Alfond Foundation will help the University of New England move the College of Osteopathic Medicine from the main campus in Biddeford to a 100,000-square-foot building in Portland, the university announced Tuesday.

Loading...

Load Error

The $30 million grant also will be used to accelerate high-growth undergraduate and graduate programs to meet student demand and workforce needs in areas like aquaculture, entrepreneurship, criminal justice and sports media communication, among others, officials said.

The move of the College of Osteopathic Medicine will put it on the Portland campus along with other health-related programs like dentistry, pharmacy, physician assistant, nursing, physical therapy, occupational therapy, social work, dental hygiene and nurse anesthesia.

“With a truly integrated health care campus, like none other in our region, our health professions students will capitalize on opportunities for cross-professional learning, enhance their team-based competencies, and will benefit from amazing new learning spaces that will complement UNE’s existing assets,” said UNE President James Herbert.

The university hopes to break ground on the new building in the spring 2022 and looks to the fall 2023 as a targeted completion date, officials said.

The grant from the Harold Alfond Foundation is part of a $500 million commitment over 12 years to provide an economic boost to the state.

“We believe that two fundamental components of a bright future for Maine are a high-quality education and a healthy population, and UNE is a significant contributor toward both of these goals,” said Greg Powell, chairman of the foundation.

Continue Reading

Source Article …

Read More →

Fusion IV Pharmaceuticals INC Finds Functional Medicine Can Help With COVID Care

 |  No Comments
 |  medicine

Los Angeles, CA – ( NewMediaWire ) – October 12, 2020 –  Fusion IV Pharmaceuticals INC provides functional medicine care for many patients and is focused on providing high-quality care during the Covid-19 pandemic. Their functional medicine approach has helped to identify many new treatment methods that can boost a person’s health and provide a substantial barrier to infection.

The Functional Approach Applied by Fusion IV Pharmaceutical INC

Functional medicine is a unique branch of treatments that Fusion IV Pharmaceutical INC has helped expand over the years. It focuses heavily on managing a person’s health through natural changes, such as adjusting their diet and their exercise routines.

In this way, functional medicine provides a unique opportunity to strengthen a person’s immune system against Covid-19. The worst symptoms of this disease are found to occur in those with weaker bodies or underlying conditions. Fusion IV Pharmaceutical INC seeks to help those with these problems by making their bodies more substantial and more resistant to diseases.

And Fusion IV Pharmaceutical INC has pioneered many care methods to make this process more streamlined and efficient. By understanding these techniques, those who are at more risk during this pandemic can decrease their potential risk and avoid severe symptoms.

Methods Used By Fusion IV Pharmaceuticals INC

At Fusion IV Pharmaceuticals INC, patients are being asked to follow the basic COVID prevention methods. These include social distancing – staying six feet away from others at all times – and washing and sanitizing hands whenever possible. Washing hands with soap for up to 20-30 seconds can help to kill many germs, including the COVID virus.

Fusion IV Pharmaceuticals INC is also creating dietary plans for patients that include healthy and unprocessed foods, cutting down on starches and unhealthy grains, and focusing on medicinal foods like spinach, cabbage, oranges, olives, and apples. These foods have flavonoids that help fight viruses, including kaempferol, hesperidin, and quercetin.

And Fusion IV Pharmaceuticals INC also provides immune-boosting treatments to help fight Covid and other conditions. These treatments include various types of supplements, such as 1,000-2,000 mg of Vitamin C, 20 mg of Zinc a day, 1-2 mg of sustained-released melatonin, and 1,200 mg of NAC every day. These supplements help keep the immune system functional and healthy.

Fusion IV Pharmaceuticals INC implements breakthrough techniques and delivery methods to enhance supplemental delivery. These include multiple infusion methods that work supplements directly into the bloodstream, making their delivery more comprehensive. Those who cannot tolerate this type of care may receive oral supplements that they can take at home.

About Fusion IV Pharmaceuticals INC

Fusion IV Pharmaceuticals INC is a compounding pharmacy that focuses on functional medicine, a patient-centered approach, and science-based care. Located in Los Angeles, California, they have helped promote wellness, better health, and medical science advances for over five years. They are led by Dr. Navid Vahedi, a passionate compounding pharmacist.

Source Article …

Read More →